Company Legal Name
Latest Valuation
Founded Year
Headquarter
Remedio Technologies operates a cybersecurity platform that provides automated device posture management solutions for enterprise environments. Founded in 2019 and headquartered in Tel Aviv, the company addresses critical security gaps by continuously monitoring and securing endpoint devices across corporate networks. Remedio's platform automates the traditionally manual process of device security assessment, enabling organizations to maintain comprehensive visibility and control over their device ecosystems. The company focuses on streamlining cybersecurity operations while reducing the complexity and resource burden typically associated with enterprise device management, positioning itself within the growing endpoint security and device management market segment.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy Remedio pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of Remedio ?
The latest valuation of Remedio is , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in Remedio ?
The minimum investment is $10, enabling fractionalized access to Remedio pre-IPO shares.
What fees will I pay when investing in Remedio pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in Remedio pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my Remedio pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.